Regulus Therapeutics
RGLS
#8339
Rank
A$0.17 B
Marketcap
$2.73
Share price
6.43%
Change (1 day)
36.51%
Change (1 year)

Regulus Therapeutics (RGLS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : A$8.9 M

According to Regulus Therapeutics's latest financial reports the company's total liabilities are A$8.9 M. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regulus Therapeutics - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31A$19.72 M6.29%
2021-12-31A$18.56 M23.53%
2020-12-31A$15.02 M-52.13%
2019-12-31A$31.39 M-34.52%
2018-12-31A$47.93 M-12.14%
2017-12-31A$54.55 M-11.8%
2016-12-31A$61.85 M164.95%
2015-12-31A$23.34 M-51.49%
2014-12-31A$48.12 M44.99%
2013-12-31A$33.19 M-16.92%
2012-12-31A$39.95 M-51.45%
2011-12-31A$82.28 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$84.06 B 943,744.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$91.25 B 1,024,549.71%๐Ÿ‡ซ๐Ÿ‡ท France
A$16.37 B 183,716.10%๐Ÿ‡บ๐Ÿ‡ธ USA
A$97.10 B 1,090,199.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$6.01 B 67,476.63%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.10 B 1,067.46%๐Ÿ‡บ๐Ÿ‡ธ USA
A$116.35 B 1,306,349.98%๐Ÿ‡บ๐Ÿ‡ธ USA